OliX Pharmaceuticals to Participate in BIO Partnering at JPM and Biotech Showcase 2022 Conferences

3 years ago

SUWON, Republic of Korea., Jan. 03, 2022 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi…

Myovant Sciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

3 years ago

BASEL, Switzerland, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women…

Todos Medical to Present at January 5, 2022 Emerging Growth Conference

3 years ago

NEW YORK, NY and TEL AVIV, Israel, Jan. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB:…

The Greenrose Holding Company Closes Asset Purchase of True Harvest, LLC

3 years ago

- True Harvest Expands Greenrose’s Footprint into Arizona and Establishes Strong Cultivation Presence in the Southwest - - Greenrose Provides…

Spero Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections including Pyelonephritis

3 years ago

The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 27, 2022CAMBRIDGE, Mass., Jan. 03,…

Allarity Therapeutics and Oncoheroes Biosciences Sign Agreements to Advance Pediatric Cancer Development of Dovitinib and Stenoparib

3 years ago

Press release        Oncoheroes will fund and advance the clinical development of both dovitinib and stenoparib in pediatric…

Ortho Clinical Diagnostics to Participate in the 40th Annual J.P. Morgan Healthcare Conference

3 years ago

RARITAN, N.J., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest…

U.S. Food and Drug Administration Approves Immix Biopharma Rare Pediatric Disease Designation for IMX-110 as a Treatment for Life-Threatening Pediatric Cancer in Children

3 years ago

Rare Pediatric Disease Designation (“RPDD”) qualifies Immix Biopharma to receive fast track review, and a priority review voucher (“PRV”) at…

InnerScope Hearing Technologies (OTC: INND) CEO to Present at The Emerging Growth Conference on Jan. 5, 2022

3 years ago

InnerScope invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at the…

Alignment Healthcare To Participate in Upcoming J.P. Morgan Healthcare Conference

3 years ago

ORANGE, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (Nasdaq: ALHC), a tech-enabled…